# Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

> **NCT03062033** · — · UNKNOWN · sponsor: **Neurocrine Biosciences** · enrollment: 70 (estimated)

## Conditions studied

- Tardive Dyskinesia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03062033
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-04
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062033, "Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03062033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*